2017
DOI: 10.1007/s40134-017-0256-2
|View full text |Cite
|
Sign up to set email alerts
|

Imaging Features of Toxicities by Immune Checkpoint Inhibitors in Cancer Therapy

Abstract: Purpose of reviewWith the increasing use of immune checkpoint inhibitors in cancer therapy radiographic profiling of frequent and serious immune-related adverse events (irAEs) becomes more relevant. This article reviews imaging features of irAEs induced by the anti-CTLA-4 and anti-PD-1 antibodies ipilimumab, nivolumab and pembrolizumab.Recent findingsImportant radiological manifestations are immune-related colitis, hepatitis, pancreatitis, hypophysitis, pneumonitis, arthritis and sarcoid-like lymphadenopathy. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
68
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 75 publications
(68 citation statements)
references
References 47 publications
(81 reference statements)
0
68
0
Order By: Relevance
“…Severe IRAEs like colitis, pneumonitis or hepatitis are rare but they can be life-threatening. 5,6 The incidence of musculoskeletal IRAEs has not been clarified yet and may be higher than shown in the literature. Different cases diagnosed with arthralgia, polymyalgia rheumatica, psoriatic arthritis, rheumatoid arthritis, myositis, myopathy, sarcoidosis, sicca syndrome, and systemic lupus erythematosus following nivolumab therapy were reported in the literature.…”
Section: Discussionmentioning
confidence: 97%
See 1 more Smart Citation
“…Severe IRAEs like colitis, pneumonitis or hepatitis are rare but they can be life-threatening. 5,6 The incidence of musculoskeletal IRAEs has not been clarified yet and may be higher than shown in the literature. Different cases diagnosed with arthralgia, polymyalgia rheumatica, psoriatic arthritis, rheumatoid arthritis, myositis, myopathy, sarcoidosis, sicca syndrome, and systemic lupus erythematosus following nivolumab therapy were reported in the literature.…”
Section: Discussionmentioning
confidence: 97%
“…3,4 The percentage of IRAEs with nivolumab was reported to be 10-15%. 5 Skin manifestations and elevated transaminases can be seen at an approximate rate of 30%. Severe IRAEs like colitis, pneumonitis or hepatitis are rare but they can be life-threatening.…”
Section: Discussionmentioning
confidence: 99%
“…Crohn's disease affects mainly terminal ileum with a patchy transmural distribution while ulcerative colitis increases intensity distally. Infectious colitis is most commonly localized in the right colon and is characterized by wall thickening with homogeneous enhancement while pseudomembranous colitis normally appears with marked circumferential or eccentric wall thickening [43]. Occasionally, the diagnosis of irAEs-related colitis is supported with biopsy which may show neutrophilic infiltrate, lymphocytic infiltrate, or a mix of both [44].…”
Section: Colonmentioning
confidence: 99%
“…US may show prominent periportal echogenicity and gallbladder wall edema (Figure 4) [47]. Differential diagnosis should be made with viral hepatitis, alcoholic liver disease, and idiopathic autoimmune hepatitis [43]. Therefore, in case of a diagnostic doubt viral serology, history of alcohol abuse, steatohepatitis, cirrhosis, and the presence of autoantibodies should be evaluated.…”
Section: Livermentioning
confidence: 99%
See 1 more Smart Citation